Clinical experience with oral methadone administration in the treatment of pain in 196 advanced cancer patients

Journal of Clinical Oncology

Volumn 14, Issue 10, 1996, Pages 2836-2842

  De Conno, F ^a   Groff, L ^a   Brunelli, C ^a   Zecca, E ^a   Ventafridda, V ^a   Ripamonti, C ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

METHADONE;

ADULT; ADVANCED CANCER; AGED; ANALGESIA; ARTICLE; CANCER PAIN; CANCER PALLIATIVE THERAPY; CLINICAL TRIAL; CONSTIPATION; DOSE RESPONSE; DROWSINESS; DRUG EFFICACY; FEMALE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PAIN ASSESSMENT; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 10144241678     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1996.14.10.2836     Document Type: Article

References (49)

1. World Health Organization: Cancer Pain Relief (ed 2). Geneva, Switzerland, World Health Organization, 1996
2. Gourlay GK, Cherry DA, Cousins MJ: A comparative study of the efficacy and pharmacokinetics of oral methadone and morphine in the treatment of severe pain in patients with cancer. Pain 25:297-312, 1986
3. Inturrisi CE, Portenoy RK, Max MB: Pharmacokinetic-pharmacodynamic relationships of methadone infusions in patients with cancer pain. Clin Pharmacol Ther 47:565-577, 1990
4. Fainsinger R, Schoeller T, Bruera E: Methadone in the management of cancer pain: A review. Pain 52:137-147, 1993
5. Nilsson MI, Meresaar U, Anggard E, et al: Clinic pharmacokinetics of methadone. Acta Anaesthesiol Scand Suppl 574:66-69, 1982
6. Inturrisi CE, Verebely K: Disposition of methadone in man after a single oral dose. Clin Pharmacol Ther 13:923-930, 1972
7. Bellward GD, Warren PM, Howald W, et al: Methadone maintenance: Effect of urinary pH on renal clearance in chronic high and low doses. Clin Pharmacol Ther 22:92-99, 1977
8. Inturrisi CE, Colburn WA, Kaiko RF, et al: Pharmacokinetics and pharmacodynamics of methadone in patients with chronic pain. Clin Pharmacol Ther 41:392-401, 1987
9. Sawe J, Hansen J, Ginman C, et al: Patient-controlled dose regimen of methadone for chronic cancer pain. Br Med J 282:771-773, 1981
10. Plummer JL, Gourlay GK, Cherry DA, et al: Estimation of methadone clearance: Application in the management of cancer pain. Pain 33:313-322, 1988
11. Beaver WT, Wallenstein SL, Houde RW, et al: A clinical comparison of the analgesic effects of methadone and morphine administered intramuscularly and of orally and parenterally administered methadone. Clin Pharmacol Ther 8:415-426, 1967
12. Ventafridda V, Ripamonti C, Bianchi M, et al: A randomized study on oral administration of morphine and methadone in the treatment of cancer pain. J Pain Symptom Manage 1:203-207, 1986
13. Grochow L, Sheidler V, Grossman S, et al: Does intravenous methadone provide longer lasting analgesia than intravenous morphine? A randomized, double-blind study. Pain 38:151-157, 1989
14. Nilsson MI, Widelov E, Meresaar U, et al: Effect of urinary pH on the disposition of methadone in man. Eur J Clin Pharmacol 22:337-342, 1982
15. Sawe J, Dahlstrom B, Paalzow L, et al: Morphine kinetics in cancer patients. Clin Pharmacol Ther 30:629-635, 1981
16. Rane A, Sawe J, Dahlstrom B, et al: Pharmacological treatment of cancer pain with special reference to the oral use of morphine. Acta Anaesthesiol Scand Suppl 576:97-99, 1982
17. Paalzow L, Nilsson L, Stenberg P, et al: Pharmacokinetic basis for optimal methadone treatment of pain in cancer patients. Acta Anaesthesiol Scand Suppl 574:55-58, 1982
18. Houde RE: Misinformation: Side effects and drug interactions, in Hill CS, Fields WS (eds): Advances in Pain Research and Therapy, vol 11, New York, NY, Raven, 1989, pp 145-161
19. Sawe J: High-dose morphine and methadone in cancer patients. Clinical pharmacokinetic considerations of oral treatment. Clin Pharmacokinet 11:87-106, 1986
20. Bruera E, Watanabe S, Fainsinger RL, et al: Custom-made capsules and suppositories of methadone for patients on high-dose opioids for cancer pain. Pain 62:141-146, 1995
21. Tamburini M, Selmi S, De Conno F, et al: Semantic descriptors of pain. Pain 25:187-193, 1987
22. De Conno F, Caraceni A, Gamba A, et al: Pain measurement in cancer patients: A comparison of six methods. Pain 57:161-166, 1994
23. Tamburini M, Rosso S, Gamba A, et al: A therapy impact questionnaire for quality-of-life assessment in advanced cancer research. Ann Oncol 3:565-570, 1992
24. Ventafridda V, De Conno F, Ripamonti C, et al: Quality-of-life assessment during a palliative care programme. Ann Oncol 1:415-420, 1990
25. Ventafridda V, De Conno F, Di Trapani P, et al: A new method of pain quantification based on weekly self-descriptive record of the intensity and duration of pain, in Bonica JJ, Lindblom U, Iggo A (eds): Advances in Pain Research and Therapy, vol 5. New York, NY, Raven, 1983, pp 891-895
26. Muers MF, Ash D, Close HJ, et al: Palliation of symptoms in non-small cell lung cancer: A study by the Yorkshire Regional Cancer Organisation thoracic group. Thorax 48:339-343, 1993
27. Kruskal WH: Ordinal measures of association. J Am Stat Assoc 53:814-861, 1958
28. Portenoy RK, Coyle N: Controversies in the long-term management of analgesic therapy in patients with advanced cancer. J Pain Symptom Manage 5:307-319, 1990
29. Crews JC, Sweeney NJ, Denson DD, et al: Clinical efficacy of methadone in patients refractory to other mu-opioid receptor agonist analgesics for management of terminal cancer pain. Cancer 72:2266-2272, 1993
30. Foley KM: Clinical tolerance to opioids, in Basbaum AI, Besson JM (eds): Towards a New Pharmacotherapy of Pain. New York, NY, Wiley, 1991, pp 181-203
31. Neil A: Studies on action mechanisms of morphine and methadone in mice. Neuropeptides 5:189-192, 1984
32. Rogers AG: The use of methadone in opioid-tolerant patients. J Pain Symptom Manage 3:45, 1988
33. Ivarsson M, Neil A: Differences in efficacies between morphine and methadone demonstrated in the guinea pig ileum: A possible explanation for previous observations on incomplete opioid cross-tolerance. Pharmacol Toxicol 65:368-371, 1989
34. Neil A: Morphine- and methadone-tolerant mice differ in cross-tolerance to other opiates. Naunyn Schmiedebergs Arch Pharmacol 320:50-53, 1982
35. Morley JS, Watt JWG, Well JC, et al: Methadone in pain uncontrolled by morphine. Lancet 342:1243, 1993
36. Glare PA, Walsh TD, Pippenger CE: Normorphine, a neurotoxic metabolite. Lancet 335:725-726, 1991
37. Hagen NA, Foley KM, Cerbone DJ, et al: Chronic nausea and morphine-6-glucuronide. J Pain Symptom Manage 6:125-128, 1991
38. Portenoy RK, Foley KM, Stulman J, et al: Plasma morphine and morphine-6-glucuronide during chronic morphine therapy for cancer pain: Plasma profiles, steady-state concentrations and the consequences of renal failure. Pain 47:13-19, 1991
39. Symonds P: Methadone and the elderly. Br Med J 1:512, 1977
40. Ettinger DS, Vitale PJ, Trump DL: Important clinical pharmacological considerations in the use of methadone in cancer patients. Cancer Treat Rep 63:457-459, 1979
41. Twycross RG: A comparison of diamorphine-with-cocaine and methadone. Br J Clin Pharmacol 4:691-693, 1977
42. Breivik H, Rennemo F: Clinical evaluation of combined treatment with methadone and psychotropic drugs in cancer patients. Acta Anaesthesiol Scand Suppl 745:135-140, 1982
43. Hansen J, Ginman C, Hartvig P, et al: Clinical evaluation of oral methadone in treatment of cancer pain. Acta Anaesthesiol Scand Suppl 745:124-127, 1982
44. Richilin DM, Jamron LM, Novick NL: Cancer pain control with a combination of methadone, amitriptyline and non-narcotic analgesic therapy: A case series analysis. J Pain Symptom Manage 2:89-94, 1987.
45. Hanks GW, Justins DM: Cancer pain: Management. Lancet 339:1031-1036, 1992
46. Nyswander ME, Dole VP: On the use of methadone to limit physical dependence in the treatment of chronic pain, in Foley KM, Inturrisi CE (eds): Advances in Pain Research and Therapy, vol 8. New York, NY, Raven, 1986, pp 187-190
47. Wachtel T, Allen-Masterson S, Reuben D, et al: The end stage cancer patient: Terminal common pathway. Hospice J 4:43-80, 1988
48. Reuben DB, Mor V, Hiris J: Clinical symptoms and length of survival in patients with terminal cancer. Arch Intern Med 148:1586-1591, 1988
49. Reuben DB, Mor V: Dyspnea in terminally ill cancer patients. Chest 89:234-236, 1986